Published in:
Open Access
01-12-2015 | Letter to the Editor
Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T
Authors:
Amir Sharafkhaneh, Jennifer Katigbak, Max Hirshkowitz, Hossein Sharafkhaneh, Saba P. Sharafkhaneh, Christie M. Ballantyne, Biykem Bozkurt, Vijay Nambi
Published in:
Respiratory Research
|
Issue 1/2015
Login to get access
Excerpt
Obstructive sleep apnea (OSA) is associated with increased risk for cardio- and cerebrovascular diseases [
1,
2]. Animal studies propose intermittent hypoxia and the resulting inappropriate activation of sympathetic nervous system [
3,
4] as the major link between OSA and cardio- and cerebrovascular comorbidities. However, the OSA severity level at which continuous positive airway pressure (CPAP) therapy offers cardio- and cerebrovascular benefit (reduction in indices of myocardial stress/injury) is a matter of debate. Sub-clinical injury to the myocardium is considered to be a precursor for the development of incident cardiovascular disease including heart failure [
5]. Troponin T measured with a high sensitivity assay (Hs-TnT) has been shown to predict incident heart failure and cardiovascular death [
6]. Further, increase or decrease in Hs-TnT over time predicted increased or decreased incidence of heart failure and cardiovascular death [
7,
8]. Hs-TnT has also shown to be increased with presence and severity of OSA [
9]. Stronger correlations were reported with nadir SpO2 [
10]. Roca and colleagues, in a cohort of 1645 subjects free of coronary artery disease and heart failure with a median follow up of 12.4 years, reported that hs-TnT was associated with risk of death or incident heart failure across various categories of OSA after adjusting for 17 potential confounders [
11]. Surprisingly, a recent study showed increased Hs-TnT after 12 months of CPAP therapy in patients with OSA. However, the utilization of CPAP was not reported [
12]. We report changes in Hs-TnT level as a marker of myocardial stress/injury in a cohort of CPAP compliant patients with OSA. …